Recent Updates
Recently added Catalysts
RDY Positive Sentiment Score: 75/100

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Friday, April 7, 2023 1 min read
Key Takeaway: Dr. Reddy's Laboratories announced the successful completion of its acquisition of Mayne Pharma's U.S. generic prescription product portfolio. This acquisition, first announced in February 2023, was finalized on April 6. The company anticipates that the integration of these products will contribute positively to its growth and expansion in the United States market.

Market Sentiment Analysis

POSITIVE FACTORS

  • Completion of acquisition enhances Dr. Reddy's product portfolio.
  • Strategic growth through acquisition of Mayne Pharma's assets.
  • Strengthened position in the U.S. generic market.

Full Press Release Details

National Stock Exchange of India Ltd. (Stock Code:
BSE Limited (Stock Code: 500124)
Sub: Update on Press Release dated February
This is in furtherance to our press release dated
February 27, 2023, titled Dr. Reddy's Laboratories announces agreement to acquire Mayne Pharma's U.S. generic prescription
product portfolio.' In this regard, we would like to inform you that the said acquisition has been completed on Thursday April 6,
Kindly take the above on your record.
For Dr. Reddy's Laboratories Limited
/s/ K Randhir Singh
K Randhir Singh
Company Secretary, Compliance Officer and Head
Cc: New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)

Frequently Asked Questions

When was the acquisition of Mayne Pharma completed?

The acquisition was completed on April 6, 2023.

What company did Dr. Reddy's acquire?

Dr. Reddy's acquired Mayne Pharma's U.S. generic prescription product portfolio.

What was the date of the initial press release?

The initial press release was on February 27, 2023.

Who is the Company Secretary of Dr. Reddy's Laboratories?

K Randhir Singh is the Company Secretary and Compliance Officer.

Tags: RDY Viatris Investor Conferences Healthcare Dr. Reddy's Laboratories Mayne Pharma U.S. generics acquisition pharmaceuticals
Last updated: Apr 7, 2023